4.1893
price down icon8.82%   -0.4007
 
loading

Finanzdaten der Voyager Therapeutics Inc-Aktie (VYGR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
19.67%
5.20
6.473 6.278 24.63 29.58
Operating Expenses
1.60%
41.83
41.17 44.58 38.41 44.60
Benefits Costs and Expenses
2.96%
38.57
37.46 40.18 33.63 39.70
Costs And Expenses
2.96%
38.57
37.46 40.18 33.63 39.70
Operating Income/Loss
5.57%
-36.62
-34.69 -38.30 -13.78 -15.03
Nonoperating Income/Loss
12.16%
3.258
3.709 4.396 4.779 4.908
Income/Loss From Continuing Operations Before Tax
7.69%
-33.37
-30.98 -33.90 -9.001 -10.12
Income Tax Expense/Benefit
59.46%
0.015
0.037 0.584 0.043 0.024
Income/Loss From Continuing Operations After Tax
7.61%
-33.38
-31.02 -34.49 -9.044 -10.14
Net Income/Loss
7.61%
-33.38
-31.02 -34.49 -9.044 -10.14
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.54%
58.67
58.35 0.1031 57.85 57.72
Diluted Average Shares
0.54%
58.67
58.35 0.1031 57.85 57.72
Basic Earnings Per Share
7.55%
-0.57
-0.53 -0.60 -0.16 -0.18
Diluted Earnings Per Share
7.55%
-0.57
-0.53 -0.60 -0.16 -0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.76
price up icon 1.09%
$28.91
price up icon 0.72%
$102.30
price up icon 0.64%
$104.01
price up icon 0.05%
biotechnology ONC
$310.12
price down icon 0.56%
$183.65
price down icon 1.35%
Kapitalisierung:     |  Volumen (24h):